168 related articles for article (PubMed ID: 11315260)
1. Alterations in cyclin D1 expression in esophageal squamous cell carcinoma in the Indian population.
Mathew R; Arora S; Khanna R; Shukla NK; Mathur M; Ralhan R
J Cancer Res Clin Oncol; 2001 Apr; 127(4):251-7. PubMed ID: 11315260
[TBL] [Abstract][Full Text] [Related]
2. Frequent alterations in the expression of tumor suppressor genes p16INK4A and pRb in esophageal squamous cell carcinoma in the Indian population.
Ralhan R; Mathew R; Arora S; Bahl R; Shukla NK; Mathur M
J Cancer Res Clin Oncol; 2000 Nov; 126(11):655-60. PubMed ID: 11079730
[TBL] [Abstract][Full Text] [Related]
3. Concomitant analysis of p16/INK4, cyclin D1, and retinoblastoma protein expression in esophageal squamous cell carcinoma.
Nakamura T; Ide H; Eguchi R; Hayashi K; Takasaki K
Hepatogastroenterology; 2003; 50(53):1321-6. PubMed ID: 14571727
[TBL] [Abstract][Full Text] [Related]
4. Changes in expression of pRb, p16 and cyclin D1 in non-small cell lung cancer: an immunohistochemical study.
Malusecka E; Zborek A; Krzyzowska-Gruca S
Folia Histochem Cytobiol; 1999; 37(1):19-24. PubMed ID: 10091946
[TBL] [Abstract][Full Text] [Related]
5. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
[TBL] [Abstract][Full Text] [Related]
6. Alterations in p53 and pRb pathways and their prognostic significance in oesophageal cancer.
Mathew R; Arora S; Khanna R; Mathur M; Shukla NK; Ralhan R
Eur J Cancer; 2002 Apr; 38(6):832-41. PubMed ID: 11937319
[TBL] [Abstract][Full Text] [Related]
7. Altered p16/MTS1/CDKN2 and cyclin D1/PRAD-1 gene expression is associated with the prognosis of squamous cell carcinoma of the esophagus.
Takeuchi H; Ozawa S; Ando N; Shih CH; Koyanagi K; Ueda M; Kitajima M
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2229-36. PubMed ID: 9815619
[TBL] [Abstract][Full Text] [Related]
8. Analysis of p53, p16(INK4a), pRb and Cyclin D1 expression and human papillomavirus in primary ovarian serous carcinomas.
Bilyk OO; Pande NT; Buchynska LG
Exp Oncol; 2011 Sep; 33(3):150-6. PubMed ID: 21956468
[TBL] [Abstract][Full Text] [Related]
9. An immunohistochemical study of p16, pRb, p21 and p53 proteins in human esophageal cancers.
Kato H; Yoshikawa M; Fukai Y; Tajima K; Masuda N; Tsukada K; Kuwano H; Nakajima T
Anticancer Res; 2000; 20(1A):345-9. PubMed ID: 10769678
[TBL] [Abstract][Full Text] [Related]
10. Cyclin D1 expression and retinoblastoma gene protein (pRB) expression in esophageal squamous cell carcinoma.
Ikeguchi M; Sakatani T; Ueta T; Kaibara N
J Cancer Res Clin Oncol; 2001 Sep; 127(9):531-6. PubMed ID: 11570573
[TBL] [Abstract][Full Text] [Related]
11. Expression of retinoblastoma gene product in respiratory epithelium and sinonasal neoplasms: relationship with p16 and cyclin D1 expression.
Schwerer MJ; Sailer A; Kraft K; Baczako K; Maier H
Histol Histopathol; 2003 Jan; 18(1):143-51. PubMed ID: 12507294
[TBL] [Abstract][Full Text] [Related]
12. HPV infection and the alterations of the pRB pathway in oral carcinogenesis.
Lim KP; Hamid S; Lau SH; Teo SH; Cheong SC
Oncol Rep; 2007 Jun; 17(6):1321-6. PubMed ID: 17487385
[TBL] [Abstract][Full Text] [Related]
13. Disruption of the RB pathway and cell-proliferative activity in non-small-cell lung cancers.
Tanaka H; Fujii Y; Hirabayashi H; Miyoshi S; Sakaguchi M; Yoon HE; Matsuda H
Int J Cancer; 1998 Apr; 79(2):111-5. PubMed ID: 9583722
[TBL] [Abstract][Full Text] [Related]
14. The role of pRB, p16 and cyclin D1 in colonic carcinogenesis.
Ayhan S; Isisag A; Saruc M; Nese N; Demir MA; Kucukmetin NT
Hepatogastroenterology; 2010; 57(98):251-6. PubMed ID: 20583423
[TBL] [Abstract][Full Text] [Related]
15. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
[TBL] [Abstract][Full Text] [Related]
16. Disruption of the p16/cyclin D1/retinoblastoma protein pathway in the majority of human hepatocellular carcinomas.
Azechi H; Nishida N; Fukuda Y; Nishimura T; Minata M; Katsuma H; Kuno M; Ito T; Komeda T; Kita R; Takahashi R; Nakao K
Oncology; 2001; 60(4):346-54. PubMed ID: 11408803
[TBL] [Abstract][Full Text] [Related]
17. [The expression of p53, p16, cyclin D1 in esophageal squamous cell carcinoma and esophageal dysplasia].
Kim SG; Hong SJ; Kwon KW; Jung SW; Kim WY; Jung IS; Ko BM; Ryu CB; Kim YS; Moon JH; Kim JO; Cho JY; Lee JS; Lee MS; Shim CS; Kim BS
Korean J Gastroenterol; 2006 Oct; 48(4):269-76. PubMed ID: 17060721
[TBL] [Abstract][Full Text] [Related]
18. Loss of cyclin D1 and p16 expression correlates with local recurrence in nasopharyngeal carcinoma following radiotherapy.
Hwang CF; Cho CL; Huang CC; Wang JS; Shih YL; Su CY; Chang HW
Ann Oncol; 2002 Aug; 13(8):1246-51. PubMed ID: 12181248
[TBL] [Abstract][Full Text] [Related]
19. Aberrant expression of G(1)/S regulators is a frequent event in sporadic pituitary adenomas.
Simpson DJ; Frost SJ; Bicknell JE; Broome JC; McNicol AM; Clayton RN; Farrell WE
Carcinogenesis; 2001 Aug; 22(8):1149-54. PubMed ID: 11470742
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma.
Okami K; Reed AL; Cairns P; Koch WM; Westra WH; Wehage S; Jen J; Sidransky D
Oncogene; 1999 Jun; 18(23):3541-5. PubMed ID: 10376532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
